Lupin Limited
LUPIN
株式のランク
#2108
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
株価
$21.30
最終同期: 2026-10-19
時価総額
$9.74B
変化（1日）
-1.83%
変化（1年）
-3.70%
国
IN
取引 Lupin Limited (LUPIN)
カテゴリー
Healthcare
Lupin Limited（LUPIN）の営業利益率
October 2026 時点の営業利益率 TTM: 25.22%
Lupin Limited の最新の財務報告と株価によると、現在の営業利益率（TTM）は 25.22% です。2024 年末時点では 38.88% でした。
Lupin Limited の営業利益率の履歴（2004 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 25.22% | -39.59% |
| 2025 | 41.75% | 7.38% |
| 2024 | 38.88% | 671.43% |
| 2023 | 5.04% | -36.04% |
| 2022 | 7.88% | -30.94% |
| 2021 | 11.41% | 26.08% |
| 2020 | 9.05% | -24.46% |
| 2019 | 11.98% | -9.99% |
| 2018 | 13.31% | -41.73% |
| 2017 | 22.84% | -3.26% |
| 2016 | 23.61% | -10.74% |
| 2015 | 26.45% | 3.77% |
| 2014 | 25.49% | 22.08% |
| 2013 | 20.88% | 18.97% |
| 2012 | 17.55% | -2.66% |
| 2011 | 18.03% | -1.53% |
| 2010 | 18.31% | 5.41% |
| 2009 | 17.37% | -18.60% |
| 2008 | 21.34% | -3.35% |
| 2007 | 22.08% | 45.74% |
| 2006 | 15.15% | 55.07% |
| 2005 | 9.77% | -51.27% |
| 2004 | 20.05% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.09% |
IN
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。